(Press-News.org) Cold Spring Harbor, NY – Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%. Novel therapies are urgently needed, as conventional and targeted approaches have not been successful and drug resistance is an increasing problem.
Previously it had been thought that poor penetration of the drugs into pancreas tumors was the main reason for treatment failure. But now a team of scientists led by Cold Spring Harbor Laboratory (CSHL) Professor David Tuveson M.D., Ph.D., shows there are other factors at work, too.
In a paper published online today in the Proceedings of the National Academy of Sciences, Dr. Tuveson's group shows that there are survival cues inside the pancreatic tumor mass. Molecules in the milieu around the cancer cells, such as Connective Tissue Growth Factor (CTGF), provide "pro-life" signals that overcome the killing power of chemotherapeutic drugs.
"In addition to drug delivery being a problem, there is also this nurturing aspect that prevents cancer cells responding to the drugs," says Tuveson.
But he and his colleagues may have found a way to prevent this. The antibody FG-3019, a molecule that is now in phase 1/2 clinical investigation as a treatment option for pancreatic cancer, binds to CTGF and prevents it from providing cells with survival cues. Those cues seem to be mediated, at least in part, through a molecule within the cell called XIAP (X-linked inhibitor of apoptosis). XIAP derives its name from its function -- an ability to help keep the cell alive by preventing a process called apoptosis, a form of cellular suicide.
The Tuveson lab used a novel mouse model for pancreatic cancer to test FG-3019. Tumors in mice treated with FG-3019 in combination with the chemotherapeutic drug gemcitabine stopped growing. Inside the tumor there was an increase in the amount of cancer cells dying through apoptosis, which was associated with a decrease in levels of XIAP. Importantly, mice treated with both FG-3019 and gemcitabine also had an increased lifespan.
This suggests that overcoming resistance to medicines in cancer may be possible using combination therapy -- co-administering molecules that help open up the tumor to drugs as well as other molecules that prevent cancer cell survival signals alongside the chemotherapeutics. Both CTGF and XIAP have been shown to be present in human pancreatic cancer tumors so combination therapy using antagonists of either molecule could be a feasible approach, says Tuveson.
There are other compounds that sensitize cancer cells to die, for example, antagonists of Bcl-2 and Bcl-xL, cellular proteins that prevent apoptosis. "These are pro-apoptosis medicines, so it's not impossible to imagine that one could target these types of pathways in cancer cells with drugs. We haven't done those studies yet but that would be the logical progression," says Tuveson, who is the Director of the Lustgarten Foundation Pancreatic Research Laboratory at CSHL and Director of Research for the Lustgarten Foundation.
INFORMATION:
"CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer" is published online in Proceedings of the National Academy of Sciences of the USA on July 8, 2013. The authors are: Albrecht Neesse, Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Mark D. Sternlicht, Todd W. Seeley, Christian Pilarsky, Duncan I. Jodrell, Suzanne M. Spong, and David A. Tuveson. The paper can be obtained online at doi: 10.1073/pnas.1300415110.
The research described in this release was supported by the following grants and funding agencies: University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, and the NIHR Cambridge Biomedical Research Centre. D.A.T. is also supported by the Lustgarten Foundation for Pancreatic Cancer Research and by the Cold Spring Harbor Laboratory Association. K.K.F. and D.A.T. were supported by European Community Grant EPC-TM-Net 256974. A.N. was supported by a Deutsche Krebshilfe Mildred Scheel postdoctoral fellowship and by a research grant of the University Medical Center Giessen and Marburg.
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for impact of its research in molecular biology and genetics. For more information, visit http://www.cshl.edu.
Written by: Edward Brydon Ph.D., Science Writer | ebrydon@cshl.edu | 516-367-6822
END
University of Texas Medical Branch at Galveston researchers have discovered that hydrogen sulfide — the pungent-smelling gas produced by rotten eggs — is a key player in colon cancer metabolism, and a potential target for therapies for the disease.
In a paper appearing online this week in the Proceedings of the National Academy of Sciences, the UTMB scientists describe cell-culture and mouse experiments demonstrating that colon cancer cells produce large amounts of hydrogen sulfide, and depend on the compound for survival and growth.
"They love it and they need it," ...
Scientists have found that key metabolites in blood – chemical 'fingerprints' left behind as a result of early molecular changes before birth or in infancy – could provide clues to a person's long-term overall health and rate of ageing in later life.
Published today in the International Journal of Epidemiology, the international study of twins led by King's College London highlights how a technique called metabolomic profiling has revealed a collection of 22 metabolites linked to ageing. One of these, linked to ageing traits such as lung function and bone mineral density, ...
Boston – As the population gets older, and the baby boomers begin to enter their 60's and 70's, one might assume that the number of trips to the emergency department will also increase. This is contradicted by new research from Brigham and Women's Hospital (BWH), which shows that population aging will not cause the number of emergency department (ED) visits to increase between now and 2050. However, visits will become longer and hospitalizations will become more frequent. This research will appear in the July issue of Health Affairs.
"With US emergency care characterized ...
CAMBRIDGE, MA -- A high level of air pollution, in the form of particulates produced by burning coal, significantly shortens the lives of people exposed to it, according to a unique new study of China co-authored by an MIT economist.
The research is based on long-term data compiled for the first time, and projects that the 500 million Chinese who live north of the Huai River are set to lose an aggregate 2.5 billion years of life expectancy due to the extensive use of coal to power boilers for heating throughout the region. Using a quasi-experimental method, the researchers ...
DARIEN, IL – A new study suggests that CPAP therapy reduces nightmares in veterans with post-traumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).
Results show that the mean number of nightmares per week fell significantly with CPAP use, and reduced nightmare frequency after starting CPAP was best predicted by CPAP compliance.
"Patients with PTSD get more motivated to use CPAP once they get restful sleep without frequent nightmares, and their compliance improves" said principal investigator Sadeka Tamanna, MD, MPH, medical director of the Sleep Disorders ...
(Santa Barbara, California) –– The North Pole isn't the only place on Earth affected by slight increases in temperature. Until recently, scientific thinking used to posit that tropical forests, which already exist in warm climates, may not be impacted much by climate change. But a new study conducted by UC Santa Barbara's National Center for Ecological Analysis and Synthesis (NCEAS) shows that to be erroneous. In fact, the results indicate that tropical forests are producing more flowers in response to only slight increases in temperature. The findings were published online ...
MENLO PARK, Calif.—July 8, 2013—A hallmark of neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's is that by the time symptoms appear, significant brain damage has already occurred—and currently there are no treatments that can reverse it. A team of SRI International researchers has demonstrated that measurements of electrical activity in the brains of mouse models of Huntington's disease could indicate the presence of disease before the onset of major symptoms. The findings, "Longitudinal Analysis of the Electroencephalogram and Sleep Phenotype ...
Defying 30 mph gusts and temperatures down to minus 22 F, NASA's new polar rover recently demonstrated in Greenland that it could operate completely autonomously in one of Earth's harshest environments.
The robot known as GROVER, which stands for both Greenland Rover and Goddard Remotely Operated Vehicle for Exploration and Research, was designed by teams of students attending engineering boot camps at Goddard in the summers of 2010 and 2011. Built to carry a ground-penetrating radar to analyze layers of snow and ice, the rover was later transferred to Boise State University ...
CHAPEL HILL, N.C. - The tyrosine kinase MerTK plays a prominent role in the body's immune response. MerTK signaling helps "calm" the body's first line of immunity, the macrophage, while it performs the routine duties - clearing cells that die and healing damaged tissue.
New evidence by a University of North Carolina-led team published online on July 8 by the Journal of Clinical Investigation shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize. The study, led ...
Corals may let certain bacteria get under its skin, according to a new study by researchers at Woods Hole Oceanographic Institution (WHOI) and King Abdullah University of Science and Technology (KAUST) and soon to be published in the journal Applied and Environmental Microbiology. The study offers the first direct evidence that Stylophora pistillata, a species of reef-building coral found throughout the Indian and west Pacific Oceans, harbors bacterial denizens deep within its tissues.
"We have evidence that other species of coral also host these bacteria, and that they ...
